Starsaber wrote:PeterZ wrote:Daryl,
http://www.fdareview.org/03_drug_development.php
http://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/
A major part of the cost of drugs are the R&D requirements. It takes 11-14 years to bring a new drug to market. The chart indicates only 8% of compounds are actually approved by the FDA. Yet testing all of them costs money. Who pays for that research if the pharmaceutical company is prohibited from charging for those expenses? The second link gives you some idea of average R&D investment and the number of drugs approved.
If there is no incentive to spend a decade and a half trying to find a new drug with a 92% of failure somewhere along the way, very few researchers would do it. Then if they succeed the company may have exclusivity for less than 10 years. The patent is often granted before clinical or even preclinical trials to prevent others from competing. So a 20 year patent may only provide less that 10 years of exclusive use of an approved drug.
R&D is a valid concern, but they could save money by not advertising so much. Prescription medicine decisions should be up to the doctor, but I can't watch a show without seeing an ad ending with "ask your doctor about..." some prescription drug that's supposed to help with a condition. If your doctor thought that was the right medicine for your situation, they'd already be prescribing it.
Perhaps, but likely not. Research suggests that advertising increases revenue. This is in part a relative measure to other similar drugs, but not totally. Some of the effects of advertising is to increase use in those that may receive only a moderate benefit from the drug. This is will tend to increase revenue and operating margin to pay for the R&D.
Trust me, if advertising did not increase revenue, they wouldn't do it. Notice how chemotherapy drugs are not advertised beyond pamphlets to oncologists. Advertising broadly for those drugs do not raise revenue.